Sandhya Yadav (@Sandhya93845546) profile picture

Department of Biological Sciences

IISER Bhopal
Joined July 2020
Sandhya Yadav retweeted
Exciting news! Our lab's publication uncovers the non-canonical role of PKM2 in breast cancer progression in hypoxia, revealing insights into poised chromatin state & epigenetic strategies & offering a promising strategy to inhibit tumor growth. academic.oup.com/narcancer/a…
8
5
2
81
5,640
Sandhya Yadav retweeted
Our new preprint ! Enhanced glycolysis in cancer cells promotes histone lactylation, driving c-Myc upregulation and alternative splicing in breast cancer. Exciting mechanistic insights into tumorigenesis! #CancerResearch #Epigenetics" @MadhuraPandkar @iiserbhopal @India_Alliance
Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression biorxiv.org/cgi/content/shor… #bioRxiv
1
5
3
50
3,560
Sandhya Yadav retweeted
Replying to @PoojaYadav_IND
@PoojaYadav_IND successfully decodes a complex mechanism on how epigenetics mediated alternative splicing regulates angiogenesis in tumor hypoxia! Congratulations team VEGFA, from ERPL🥳@PoojaYadav_IND @anchala97 @KakaniParik @Mutnuru_SA @sanjeevtmc sciencedirect.com/science/ar…
1
4
34
1,725
Excited to share the story of hypoxic non-canonical PKM2 and its adventures! Presenting the preprint of my PhD work which reveals fascinating insights into PKM2-mediated epigenetic regulation of PFKFB3 that drives breast cancer progression under hypoxia. biorxiv.org/content/10.1101/…
1
1
2
34
Congratulations to @anchala97 and @PoojaYa18201802 for putting together an article on "Unfolding the role of autophagy in the cancer metabolism" sciencedirect.com/science/ar…
4
17
Sandhya Yadav retweeted
Congratulations to all PMRF recipients.
Congratulations to Midhun, M, Aniruddha S, Manav Mishra, Divya Bindra, Anchala Pandey, Nilanjana Das, Mr. Bhaskar De, Urvashi, and Saurabh Rai for their selection for the PMRF scheme - May 2021 cycle. @PMOIndia @EduMinOfIndia @PrinSciAdvGoI @IndiaDST @DBTIndia @UmapathyIndia
1
1
13
Sandhya Yadav retweeted
We are glad to share our latest work on the ERK1/2-EGR1-SRSF10 axis and alternative splicing in head and neck cancer. Congratulations to @Sandhya93845546. Thank you @India_Alliance @serbonline @DAEIndia @iiserbhopal.
New Research: ERK1/2-EGR1-SRSF10 Axis Mediated Alternative Splicing Plays a Critical Role in Head and Neck Cancer: Aberrant alternative splicing is recognized to promote cancer pathogenesis, but the underlying mechanism is yet to be clear.… frontiersin.org/articles/10.… #celldevbio
7
7
52
Sandhya Yadav retweeted
We are excited to share our recent work on hypoxia-driven epigenetic reprogramming that regulates the expression of a splicing factor to contribute to breast cancer progression. Thank you, @India_Alliance, for supporting our work. nature.com/articles/s41389-0…
17
16
7
145
Sandhya Yadav retweeted
Replying to @arpita_yadav_
1
2
Sandhya Yadav retweeted
We are glad to share our one-stop source for a comprehensive review on RNA processing and tumor microenvironment @sanjeevtmc, @ERPLab_IISERB, @IISERB, @India_alliance, @DhamdhereShruti, @SNATUA, @MutnuruA onlinelibrary.wiley.com/doi/…
6
6
2
74
Sandhya Yadav retweeted
You can read our latest article on hypoxia-induced alternative splicing in human diseases published in Cell Mol Life Sci; rdcu.be/ccYFV. Congratulations Subhashis and Ashok from our lab @ERPLab_IISERB @SNATUA @CheemalaAshok @iiserbhopal @India_Alliance
4
7
1
62
Congratulations Dr. Richa Mishra @XploreImmunity. Another graduate from @HKlab_tweets with flying colors🎊🎉. Cheers!
1
1
2
42
Sandhya Yadav retweeted
Happy to announce SERB-STAR (Science and Technology Award for Research) awardees for 2020. Congratulations and all the best for their research endeavors!
7
3
1
60
Sandhya Yadav retweeted
Pleased to share that IISER Bhopal has ranked 26th best institution in India, and among top 1000 institutions in the world as per the recently announced Times Higher Education World University Rankings 2021. @EduMinOfIndia @DrRPNishank @RenuSwarup @PMOIndia @PrinSciAdvGoI
2
41
5
198